Skip to content

S. 5040 · 118th Congress (2023–2025)

Protecting Patients from Deceptive Drug Ads Online Act

A bill to provide for the regulation of certain communications regarding prescription drugs.

CRS summary not yet available.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 5040’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Richard J. Durbin (D-IL)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Sen. Mike Braun (R-IN)· Original · Sep 12, 2024
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Congressional Record S6021–S6022

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources
  3. Expired

    Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Sep 12, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (2)
  1. Protecting Patients from Deceptive Drug Ads Online Act

    Display title, Short title · Introduced in Senate

  2. A bill to provide for the regulation of certain communications regarding prescription drugs.

    Official title · Introduced in Senate